ReviewFrontiers in chemistry2026
Recent advances in ultrasound microbubble-mediated gold-based nanomaterials for cancer theranostics.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the realm of oncology, precision cancer diagnosis and treatment is a current research emphasis and development trend. Its main objective is to accomplish closed-loop management of "early diagnosis - precise treatment - real-time monitoring" in order to increase the effectiveness of diagnosis and treatment while lowering toxic and adverse therapeutic effects. Because of their special optical, electrical, and biocompatible benefits, gold-based nanomaterials have demonstrated wide application prospects in tumor imaging and treatment. Ultrasound microbubbles (UMBs) are a novel form of ultrasonic contrast agent and drug delivery vehicle with superior biocompatibility, ultrasonic responsiveness, and targeted modification potential. As powerful delivery vehicles, UMBs play an increasingly vital role in clinical theranostics by efficiently mediating the targeted delivery, controlled release, and synergistic therapeutic effects of gold-based nanomaterials. The varieties of UMBs, the categorization of gold-based nanomaterials, and the advancements in research on their applications in common malignancies are the main topics of this mini-review. Lastly, it provides pertinent references for the study and clinical applications of UMB-mediated gold-based nanomaterials in cancer diagnosis and treatment. It also briefly examines the present research prospects and obstacles and looks forward to future development paths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.